Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Bounce Mobile Systems
Market Cap: US$4.4m
Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
BNCM
US$0.0074
7D
0%
1Y
n/a
Regional Health Properties
Market Cap: US$4.4m
Operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living.
RHEP
US$2.60
7D
12.1%
1Y
-4.7%
Fuse Medical
Market Cap: US$4.4m
Manufactures and distributes medical devices in the United States.
FZMD
US$0.061
7D
0%
1Y
-25.7%
Filament Health
Market Cap: US$4.4m
Operates as a clinical-stage natural psychedelic drug development company in Canada.
FLHL.F
US$0.017
7D
-2.9%
1Y
-58.0%
Centogene
Market Cap: US$4.4m
Provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific.
CNTG.F
US$0.14
7D
0%
1Y
-61.8%
Raphael Pharmaceutical
Market Cap: US$4.4m
A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.
RAPH
US$0.22
7D
0%
1Y
n/a
Enzolytics
Market Cap: US$4.3m
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
ENZC
US$0.0007
7D
-17.6%
1Y
-81.7%
Visionflex Group
Market Cap: AU$6.7m
Together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia.
VFX
AU$0.002
7D
0%
1Y
-66.7%
Adial Pharmaceuticals
Market Cap: US$4.3m
A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
ADIL
US$0.66
7D
9.4%
1Y
-57.6%
Aptose Biosciences
Market Cap: CA$6.0m
A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.
APS
CA$2.36
7D
6.8%
1Y
-95.1%
Indiva
Market Cap: CA$5.9m
Engages in the production, processing, and sale of cannabis and cannabis related products in Canada.
NDVA.H
CA$0.03
7D
0%
1Y
-45.5%
Dermata Therapeutics
Market Cap: US$4.3m
A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.
DRMA
US$0.79
7D
-2.4%
1Y
-81.2%
Caduceus Software Systems
Market Cap: US$4.3m
Through its subsidiary, McLovin's Pet Food, Inc., operates as a pet food and pet care company.
CSOC
US$0.007
7D
20.7%
1Y
-58.7%
Encision
Market Cap: US$4.3m
A medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States.
ECIA
US$0.36
7D
-14.3%
1Y
-28.0%
Dogecoin Cash
Market Cap: US$4.3m
Through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.
CBDS
US$0.031
7D
24.1%
1Y
52.6%
Quest PharmaTech
Market Cap: CA$5.9m
A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.
QPT
CA$0.035
7D
0%
1Y
75.0%
KMA Holding
Market Cap: US$4.2m
Through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States.
MCDA
US$0.0001
7D
0%
1Y
n/a
T2 Biosystems
Market Cap: US$4.2m
An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.
TTOO
US$0.16
7D
25.1%
1Y
-97.1%
Azitra
Market Cap: US$4.2m
An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.
AZTR
US$0.27
7D
-8.4%
1Y
-95.1%
Nuwellis
Market Cap: US$4.2m
A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
NUWE
US$0.94
7D
-4.9%
1Y
-89.6%
Oragenics
Market Cap: US$4.2m
A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.
OGEN
US$0.20
7D
18.6%
1Y
-91.4%
Nu-Med Plus
Market Cap: US$4.2m
A medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.
NUMD
US$0.05
7D
0%
1Y
3.6%
Optimus Healthcare Services
Market Cap: US$4.2m
Provides community-based oncology practices with the necessary infrastructure and support to enroll their patients on clinical trials in the United States.
OHCS
US$0.08
7D
0%
1Y
0%
Sweet Earth Holdings
Market Cap: CA$5.8m
Does not have significant operations.
SE
CA$0.45
7D
-16.7%
1Y
28.6%
ARCpoint
Market Cap: CA$5.8m
Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States.
ARC
CA$0.045
7D
-40.0%
1Y
-52.6%
Aclarion
Market Cap: US$4.0m
Operates as a healthcare technology company in the United States.
ACON
US$6.94
7D
-2.3%
1Y
-99.8%
CompuMed
Market Cap: US$4.0m
An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.
CMPD
US$3.80
7D
15.2%
1Y
123.5%
Trellus Health
Market Cap: UK£3.0m
Provides digital chronic condition management solutions for employers and health plans.
TRLS
UK£0.018
7D
0%
1Y
12.1%
ATI Physical Therapy
Market Cap: US$4.0m
Operates as an outpatient physical therapy provider that provides outpatient rehabilitation and adjacent healthcare services through its clinics in the United States.
ATIP
US$0.90
7D
5.3%
1Y
-82.0%
Matinas BioPharma Holdings
Market Cap: US$3.9m
A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.
MTNB
US$0.87
7D
23.8%
1Y
-89.7%
Mosaic ImmunoEngineering
Market Cap: US$3.9m
A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.
CPMV
US$0.54
7D
-5.9%
1Y
35.0%
Mitesco
Market Cap: US$3.9m
Provides cloud computing, application hosting, and other data center related applications.
MITI
US$0.39
7D
-3.0%
1Y
37.9%
ProtoKinetix
Market Cap: US$3.9m
A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).
PKTX
US$0.0089
7D
-11.5%
1Y
-40.4%
Adherium
Market Cap: AU$6.1m
Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.
ADR
AU$0.008
7D
0%
1Y
-52.9%
Lixte Biotechnology Holdings
Market Cap: US$3.9m
A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.
LIXT
US$1.38
7D
13.5%
1Y
-43.9%
Galecto
Market Cap: US$3.9m
A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
GLTO
US$2.88
7D
4.9%
1Y
-81.5%